Gracell Biotechnologies (GRCL) Stock

Does Gracell Biotechnologies Inc. Sponsored ADR (GRCL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Gracell Biotechnologies Inc. Sponsored ADR (GRCL) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Does Gracell Biotechnologies Inc. Sponsored ADR (GRCL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Gracell Biotechnologies Inc. (NASDAQ:GRCL ) Q3 2023 Earnings Conference Call November 13, 2023 8:00 AM ET Company Participants William Cao - Chairman and CEO Wendy Li - Chief Medical Officer Kevin Xie - CFO Conference Call Participants Yigal Nochomovitz - Citi Benjamin Burnett - Stifel Dev Prasad - Jefferies Eric Schmidt - Cantor Emily Bodnar - H.C. Wainwright Yanan Zhu - Wells Fargo Securities Joseph Catanzaro - Piper Sandler Justin Zelin - BTIG Operator Ladies and gentlemen, thank you for standing by.

Gracell Biotechnologies (GRCL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Oral presentation of the updated results from ongoing Phase 1 investigator-initiated study of GC012F in frontline setting for transplant-eligible, high-risk newly diagnosed multiple myeloma

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune disease, today announced that the management team will participate in four upcoming investor conferences in November. Stifel 2023 Healthcare Conference Fireside Chat: Tuesday, November 14th at 1:15 pm ETOne-on-one meetings: November 14th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: New York Jefferies London Healthcare Conference Fireside Chat: Wednesday, November 15th at 11:30 am GMT / 6:30 am ETOne-on-one meetings: November 15th and 16th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: London Piper Sandler 35 th Annual Healthcare Conference Presentation: Tuesday, November 28th at 12:00 pmOne-on-one meetings: November 28th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: New York 6th Annual Evercore ISI HealthCONx Conference Presentation: Wednesday, November 29th at 9:35 am ETOne-on-one meetings: November 29th and 30th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: Miami Available webcasts of the presentations will be posted on the News and Events section of the Company's website.

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences.

Gracell Biotechnologies Inc. Sponsored ADR (GRCL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.